Study on effect of Zhixinkang Capsule in treating unstable effort angina and hyperlipidemia and its function in vascular endothelium protection

Zhang Wen-gao; Yan Ting-xiang; Gao Fu-jun; Meng Xian-zhong; Liu Jian-ping; Yin Ge-ping; Liu Li-li; Luo Nan-ping; Shi Bing-e; Ma Xue-sheng

doi:10.1007/BF02836349

Your Location：

Home >

Browse articles >

Study on effect of Zhixinkang Capsule in treating unstable effort angina and hyperlipidemia and its function in vascular endothelium protection

Updated：2021-08-27

- Study on effect of Zhixinkang Capsule in treating unstable effort angina and hyperlipidemia and its function in vascular endothelium protection
- Chinese Journal of Integrative Medicine Vol. 9, Issue 1, Pages: 25-30(2003)
- Affiliations：
  
  1. Shandong University of TCM,Jinan
  2. Jinan Mengs Institute of Biological Technology,China
  3. Jinan Military Regional General Hospital,China
  4. The First People’s Hospital of Jinan,China
- Author bio：
- Funds：
  
  study was funded by Natural Science Foundation of Shandong Province (No. Y97C22058)
- DOI：10.1007/BF02836349
  CLC：
- Published：2003，
Scan for full text
Wen-gao, Z., Ting-xiang, Y., Fu-jun, G. et al. Study on effect of Zhixinkang Capsule in treating unstable effort angina and hyperlipidemia and its function in vascular endothelium protection., Chin. J. Integr. Med. 9, 25–30 (2003). https://doi.org/10.1007/BF02836349

Zhang Wen-gao, Yan Ting-xiang, Gao Fu-jun, et al. Study on effect of Zhixinkang Capsule in treating unstable effort angina and hyperlipidemia and its function in vascular endothelium protection. [J]. Chinese Journal of Integrative Medicine 9(1):25-30(2003)
Wen-gao, Z., Ting-xiang, Y., Fu-jun, G. et al. Study on effect of Zhixinkang Capsule in treating unstable effort angina and hyperlipidemia and its function in vascular endothelium protection., Chin. J. Integr. Med. 9, 25–30 (2003). https://doi.org/10.1007/BF02836349 DOI：

Zhang Wen-gao, Yan Ting-xiang, Gao Fu-jun, et al. Study on effect of Zhixinkang Capsule in treating unstable effort angina and hyperlipidemia and its function in vascular endothelium protection. [J]. Chinese Journal of Integrative Medicine 9(1):25-30(2003) DOI： 10.1007/BF02836349.

摘要

Objective:To observe the clinical effect and protection of vascular endothelium of Zhixinkang Capsule (ZXKC) in middle-aged and old people with unstable effort angina and hyperlipidemia.Methods: Sixty-five patients with unstable effort angina were randomly divided into ZXKC group (34 cases) and control group (31 cases). Conventional western medical therapy was given to both groups

with ZXKC group receiving additional ZXKC treatment. Data of 20 healthy persons were taken as normal group. Forty-eight patients with hyperlipidemia were divided into ZXKC group treated with ZXKC (31 cases) and control group treated with Yixintong (17 cases). The changes of clinical symptoms and laboratory indexes in all the patients were observed before and after treatment.Results: In patients with unstable effort angina

the efficacy of treatment of ZXKC

the withdrawal rate of nitroglycerin

the relieving of symptoms

the improvement of the electrocardiogram

the counts of circulating endothelial cells

the content of platelet P-selectin

the content of plasma endothelin (ET)

the activity of Superoxide dismutase (SOD) and the activity of malonyldialdehyde (MDA) were all better than those in the control group. In patients with hyperlipidemia

there was no significant difference in lipids reduction between ZXKC group and the control group. In both groups

the total cholesterol (TC)

triglyceride (TG)

low density lipoprotein-cholesterol (LDL-C)

lipoprotein(a) [Lp(a)]

oxidized low density lipoprotein

MDA

arteriosclerotic index (AI) all lowered obviously

while the SOD

HDL-C and calcitonin gene-related peptide (CGRP) were all elevated markedly. In the ZXKC group

the nitric oxide (NO) increased significantly whereas the ET/CGRP and ET/NO decreased markedly. The total effective rate in symptom relieving

the markedly effective rate

the reduction of TC

ET and ET/CGRP

and the elevation of SOD in ZXKC group were all superior to those in the control group.Conclusion: ZXKC could effectively resist myocardial ischemia

relieve angina

reduce blood lipids

protect vascular endothelial cells

inhibit the activation of platelets

and resist lipid peroxidation.

Abstract

the efficacy of treatment of ZXKC

the withdrawal rate of nitroglycerin

the relieving of symptoms

the improvement of the electrocardiogram

the counts of circulating endothelial cells

the content of platelet P-selectin

the content of plasma endothelin (ET)

the activity of Superoxide dismutase (SOD) and the activity of malonyldialdehyde (MDA) were all better than those in the control group. In patients with hyperlipidemia

there was no significant difference in lipids reduction between ZXKC group and the control group. In both groups

the total cholesterol (TC)

triglyceride (TG)

low density lipoprotein-cholesterol (LDL-C)

lipoprotein(a) [Lp(a)]

oxidized low density lipoprotein

MDA

arteriosclerotic index (AI) all lowered obviously

while the SOD

HDL-C and calcitonin gene-related peptide (CGRP) were all elevated markedly. In the ZXKC group

the nitric oxide (NO) increased significantly whereas the ET/CGRP and ET/NO decreased markedly. The total effective rate in symptom relieving

the markedly effective rate

the reduction of TC

ET and ET/CGRP

and the elevation of SOD in ZXKC group were all superior to those in the control group.Conclusion: ZXKC could effectively resist myocardial ischemia

relieve angina

reduce blood lipids

protect vascular endothelial cells

inhibit the activation of platelets

and resist lipid peroxidation.

关键词

unstable effort anginahyperlipidemiaZhixinkang capsuleprotection of vascular endotheliumtherapy of traditional Chinese medicine

Keywords

unstable effort anginahyperlipidemiaZhixinkang capsuleprotection of vascular endotheliumtherapy of traditional Chinese medicine

references

Nomenclature and Diagnostic Standard for Ischemic Heart Disease. Combined Special Group on Nomenclature Standardization of the International Cardiology Association and WHO. J Chin Cardiovas Dis 1981;9(1): 75.

Guiding Principles of Clinical Research on New Chinese Drugs (Part II). Ministry of Health, PRC 1995: 171.

SU CL, SHENG SG. Modern Cardiology of TCM. Beijing: Beijing Science and Technology Press, 1997: 529–534.

CHEN KJ, LIAO JZ, XIAO ZX. Research on Cardio-cerebro-vascular Diseases. Shanghai: Shanghai Science and Technology Press, 1988: 318–319.

Guiding Principles in Clinical Research on New Chinese Drugs in Treating Senile Diseases. Administration of Pharmaceutic Affair, Ministry of Health, PRC. J Chin Med Pharm 1989; 4(3): 72.

YANG LX, ZHANG CD. Correlative research on circulating endothelial cells and plasma endothelin in patients with coronary heart disease. J Clin Cardiovasc Dis 1995; 11 (5): 273.

Rand ML, Sangrar W, Hancock MA, et al. Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN. Arterioscler Thromb Vasc Biol1998;18 (9): 1393–1399.

FULL TEXT LINK

More>

Views

353

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effects of Xuezhikang capsule on blood lipids, platelet activation and coagulation-fibrinolysis activity in patients with hyperlipidemia

Effect of Xuezhikang Capsule (血脂康胶囊) on serum tumor necrosis factor-α and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia

Effect of Taizhi’an capsule combined with Simvastatin on hyperlipidemia in diabetic patients

Effect of theo-polyphenols on hepatic histology of hyperlipidemia model in quails

Effect of astragalus- angelica mixture on lipoprotein lipase and lecithin- cholesterol acyltransferase of nephrotic rats

Related Author

No data

Related Institution

Department of Cardiology, Affiliated Hospital, Tongji Medical College, Huazhong University of Science and Technology

Guangdong Provincial Institute of Cardiovascular Diseases

Department of Traditional Chinese Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University

Department of Hepatology, Zhejiang Hospital of Traditional Chinese Medicine

Department of Endocrinology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰